Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Ekenna Elikee

Ekenna Elikee

Ekenna Natures Ltd., Nigeria

Title: Efficacy of detogen-B, a medicinal plant formulation in cancer diseases

Biography

Biography: Ekenna Elikee

Abstract

Recent global statistics shows that cancers claim more than 8 million lives, while kidney diseases register up to one million cases annually, with most cases defying even the conventional orthodox medications. Hence, there is always need to explore alternative approaches to effective cures. Some cases of cancer and kidney failure that have been established in teaching hospitals or licensed diagnostic laboratories were subjected to our extemporaneous herbal preparations from already researched plants with established phytochemical properties. Histories of patients’ diets were taken, and the toxicological properties of the food additives noted as possible risk factors in the disease conditions. Following our treatment protocol, patients with cancers of the liver, cervix, bone, lungs including cirrhosis, fatty liver and severe kidney diseaseshave recovered and are now stable. Laboratory evidences from CT scans, X-ray images, and Bence Jones protein clearance tests were obtained. The first-line drug in these treatments is Detogen-B. This herbal formulation has passed through sub-acute and sub-chronic toxicity tests conducted by the Nigeria Natural Medicine Development Agency (NNMDA), under the auspices of the Federal Ministry of Science and Technology, in conjunction with the Lagos University Teaching Hospital (LUTH). Animal organ tests showed a graphical increase in the mean weights of the liver, pancreas and lungs showing its activity in the regeneration of tissues. Reduction of LDL and triglycerides levels showed its detoxification and cardiovascular effects. The Haematological profile shows increase in the levels of WBC, MCH, MCHC and platelets without changes in the levels of RBC and procalcitonin. All these are indications of the effects of Detogen-B in the treatment of lesions, cancers, haemangioma and very degenerative disease conditions with immunostimulatory effects.